Article Versions Notes

Leotta CG, Barbaraci C, Fiorito J, Coco A, di Giacomo V, Amata E, Marrazzo A, Pitari GM. HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic. Pharmaceuticals. 2025; 18(2):179. https://doi.org/10.3390/ph18020179

Leotta, Claudia Giovanna, Carla Barbaraci, Jole Fiorito, Alessandro Coco, Viviana di Giacomo, Emanuele Amata, Agostino Marrazzo, and Giovanni Mario Pitari. 2025. "HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic" Pharmaceuticals 18, no. 2: 179. https://doi.org/10.3390/ph18020179

Leotta, C. G., Barbaraci, C., Fiorito, J., Coco, A., di Giacomo, V., Amata, E., Marrazzo, A., & Pitari, G. M. (2025). HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic. Pharmaceuticals, 18(2), 179. https://doi.org/10.3390/ph18020179